The PJ Pod

56 Folgen

1. BTK inhibitors: what pharmacists need to know

   Vom: 5.10.2023
2. Spotlight: the story behind the ADHD prescribing surge

   Vom: 28.7.2023
3. End-of-life drugs at home: closing the care gap

   Vom: 14.6.2023
4. Spotlight: Questions over Pharmacy First

   Vom: 1.6.2023
5. Psychedelic drugs: the new frontier for mental health

   Vom: 17.5.2023
6. Spotlight: The truth about weight-loss injections

   Vom: 5.5.2023
7. Coping with the ‘Davina effect’ on HRT

   Vom: 20.4.2023
8. Spotlight: Ethnicity and the pharmacy degree

   Vom: 30.3.2023
9. Effective deprescribing: getting the most from medicine

   Vom: 7.3.2023
10. Spotlight: The ‘new thalidomide’

    Vom: 23.2.2023
11. Building bridges: pharmacists reaching out to help their communities

    Vom: 26.1.2023
12. What will be the big stories in 2023?

    Vom: 16.12.2022
13. What does it take to become a consultant pharmacist?

    Vom: 24.11.2022
14. Anticholinergic drugs and dementia: a causal link?

    Vom: 5.10.2022
15. Immune-related cancer toxicities: what pharmacists need to know

    Vom: 23.8.2022
16. NICE type 2 diabetes update: what do you need to know?

    Vom: 28.7.2022
17. Pharmacogenomic testing: coming to a community pharmacy near you

    Vom: 26.5.2022
18. Myth-busting acute pain and its treatment

    Vom: 21.4.2022
19. Pandemic plus? The antibiotic resistance lurking in our rivers

    Vom: 23.3.2022
20. Can antiviral drugs turn the tide on COVID-19?

    Vom: 3.2.2022